{"id":23939,"date":"2024-03-08T13:02:29","date_gmt":"2024-03-08T21:02:29","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/"},"modified":"2024-07-09T16:56:11","modified_gmt":"2024-07-09T23:56:11","slug":"decoding-graft-versus-host-disease-types-symptoms-and-treatments","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/","title":{"rendered":"Descifrando la enfermedad de injerto contra hu\u00e9sped: tipos, s\u00edntomas y tratamientos"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">La enfermedad de injerto contra hu\u00e9sped (EICH) es una de las complicaciones comunes del trasplante alog\u00e9nico, un procedimiento en el que se trasplantan c\u00e9lulas madre sanas de un donante al cuerpo del paciente. La EICH se produce cuando algunas de las c\u00e9lulas del donante reci\u00e9n trasplantado (injerto) no reconocen el cuerpo del paciente (hu\u00e9sped) y atacan a sus c\u00e9lulas sanas.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-4018f2d1f2d74e6c22625a7317923aca\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHable con un especialista sobre la asistencia con los copagos\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">La presencia de un gl\u00f3bulo blanco espec\u00edfico (linfocito T) del donante reconoce los tejidos u \u00f3rganos del paciente como una amenaza extra\u00f1a e inicia una respuesta inmunitaria contra ellos.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">El riesgo de enfermedad de injerto contra hu\u00e9sped es mayor en personas que reciben un trasplante de un donante no compatible. Hasta <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538235\/#:~:text=Graft%2Dversus%2Dhost%20disease%20(GvHD)%20is%20a%20systemic,the%20tissues%20of%20the%20recipient.\"><span style=\"font-weight: 400;\">50% de pacientes<\/span><\/a><span style=\"font-weight: 400;\"> Experimente esta complicaci\u00f3n durante el trasplante alog\u00e9nico.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La EICH puede variar de leve a grave y, en algunos casos, puede poner en peligro la vida si no se trata a tiempo.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Este art\u00edculo explica brevemente qu\u00e9 es la EICH, c\u00f3mo se produce y qu\u00e9 esperar si la desarrolla.\u00a0<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#How_Does_Graft-Versus-Host_Disease_Develop\" >\u00bfC\u00f3mo se desarrolla la enfermedad de injerto contra hu\u00e9sped?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#What_Are_the_Types_of_Graft-Versus-Host_Disease\" >\u00bfCu\u00e1les son los tipos de enfermedad de injerto contra hu\u00e9sped?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#Who_Is_at_High_Risk_of_Developing_GvHD\" >\u00bfQui\u00e9n tiene un alto riesgo de desarrollar EICH?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#How_Is_GvHD_Diagnosed_and_Treated\" >\u00bfC\u00f3mo se diagnostica y se trata la EICH?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#Are_There_Any_Potential_Benefits_of_Graft-Versus-Host_Disease\" >\u00bfExisten beneficios potenciales de la enfermedad de injerto contra hu\u00e9sped?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#How_Can_GvHD_Be_Prevented_in_Patients_Undergoing_Allogeneic_Transplantation\" >\u00bfC\u00f3mo se puede prevenir la EICH en pacientes sometidos a trasplante alog\u00e9nico?<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Graft-Versus-Host_Disease_Develop\"><\/span>\u00bfC\u00f3mo se desarrolla la enfermedad de injerto contra hu\u00e9sped?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Generalmente, el sistema inmunitario del cuerpo entrena a las c\u00e9lulas inmunitarias para distinguir entre las c\u00e9lulas propias (sus c\u00e9lulas) y las c\u00e9lulas ajenas (c\u00e9lulas infectadas o pat\u00f3genos). En particular, los linfocitos T desempe\u00f1an esta importante funci\u00f3n y reconocen las c\u00e9lulas propias del cuerpo y los intrusos extra\u00f1os.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Esto se logra detectando la presencia de prote\u00ednas espec\u00edficas llamadas ant\u00edgenos leucocitarios humanos (HLA) o prote\u00ednas del complejo mayor de histocompatibilidad (MHC) en las c\u00e9lulas. La prote\u00edna HLA es como una etiqueta con el nombre de cada c\u00e9lula y se presenta en dos tipos:\u00a0<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">MHC clase I: presente en todas las c\u00e9lulas nucleadas de su cuerpo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">MHC clase II: presente \u00fanicamente en las c\u00e9lulas presentadoras de ant\u00edgenos (c\u00e9lulas inmunitarias)<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Cada individuo hereda un patr\u00f3n \u00fanico de prote\u00edna HLA de sus padres, excepto los gemelos id\u00e9nticos.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Tras un trasplante de c\u00e9lulas madre (alog\u00e9nico), la m\u00e9dula \u00f3sea comienza a producir nuevas c\u00e9lulas sangu\u00edneas a partir de las c\u00e9lulas madre del donante. Estas nuevas c\u00e9lulas sangu\u00edneas tienen el patr\u00f3n HLA del donante. Cuando las c\u00e9lulas T reci\u00e9n producidas se encuentran con el patr\u00f3n HLA de las c\u00e9lulas del cuerpo, las toman como extra\u00f1as (c\u00e9lulas ajenas) e inician una serie de respuestas inmunitarias. Esta respuesta inflamatoria de las c\u00e9lulas donadas ataca y da\u00f1a los tejidos del hu\u00e9sped, lo que a veces provoca insuficiencia multiorg\u00e1nica.\u00a0<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Types_of_Graft-Versus-Host_Disease\"><\/span>\u00bfCu\u00e1les son los tipos de enfermedad de injerto contra hu\u00e9sped?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La EICH puede manifestarse como EICH aguda y EICH cr\u00f3nica, dependiendo del momento de aparici\u00f3n y la duraci\u00f3n de los s\u00edntomas despu\u00e9s del trasplante.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">EICH aguda<\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"297\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea.jpg\" alt=\"Woman with graft-versus-host disease suffering from nausea\" class=\"wp-image-23942\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea-300x212.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea-86x61.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea-167x118.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea-280x198.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/nausea-370x262.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">La EICH aguda suele desarrollarse dentro de los 3 meses posteriores al trasplante y puede afectar la piel, el sistema gastrointestinal o el h\u00edgado. Los s\u00edntomas de la EICH aguda a veces comienzan m\u00e1s tarde. Los siguientes son algunos s\u00edntomas comunes que puede esperar si desarrolla una forma aguda de EICH:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Erupci\u00f3n o lesiones similares a ampollas en las palmas de las manos, las plantas de los pies, los hombros y la nuca (que se observan en <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538235\/#:~:text=Graft%2Dversus%2Dhost%20disease%20(GvHD)%20is%20a%20systemic,the%20tissues%20of%20the%20recipient.\"><span style=\"font-weight: 400;\">70%<\/span><\/a><span style=\"font-weight: 400;\"> de casos)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Problemas gastrointestinales como diarrea intensa, n\u00e1useas, v\u00f3mitos, ulceraci\u00f3n de la mucosa y dolor abdominal (observados en <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538235\/#:~:text=Graft%2Dversus%2Dhost%20disease%20(GvHD)%20is%20a%20systemic,the%20tissues%20of%20the%20recipient.\"><span style=\"font-weight: 400;\">74%<\/span><\/a><span style=\"font-weight: 400;\"> de casos)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Problemas hep\u00e1ticos como <\/span><span style=\"font-weight: 400;\">ictericia, niveles elevados de enzimas hep\u00e1ticas (<\/span><span style=\"font-weight: 400;\">bilirrubina y fosfatasa alcalina), <\/span><span style=\"font-weight: 400;\">y orina de color amarillo p\u00e1lido (observada en <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538235\/#:~:text=Graft%2Dversus%2Dhost%20disease%20(GvHD)%20is%20a%20systemic,the%20tissues%20of%20the%20recipient.\"><span style=\"font-weight: 400;\">44%<\/span><\/a><span style=\"font-weight: 400;\"> de casos).<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">EICH cr\u00f3nica<\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La EICH cr\u00f3nica puede desarrollarse en cualquier momento despu\u00e9s de un trasplante; sin embargo, es m\u00e1s com\u00fan que ocurra dentro de los dos a\u00f1os. Los s\u00edntomas de la enfermedad cr\u00f3nica son m\u00e1s graves que los de la EICH aguda y afectan a m\u00faltiples \u00f3rganos y sistemas del cuerpo, como la boca, la piel, los pulmones, el h\u00edgado, los genitales, los m\u00fasculos del tracto gastrointestinal y las articulaciones.&nbsp;&nbsp;<\/span><br><span style=\"font-weight: 400;\">Los s\u00edntomas de la EICH cr\u00f3nica pueden incluir:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Cambios en la piel (sarpullido o picaz\u00f3n)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Cambios en la visi\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ojos secos o llagas en la boca<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor articular<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatiga<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Problemas gastrointestinales como calambres, n\u00e1useas, v\u00f3mitos o diarrea.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Enfermedad de las enc\u00edas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">debilidad muscular<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecciones recurrentes<\/span><\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-e1aad7ba3b765507e60e359812bbe8b5\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfPuede ayudar la IgIV? | Informaci\u00f3n gratuita sobre el tratamiento con IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Is_at_High_Risk_of_Developing_GvHD\"><\/span>\u00bfQui\u00e9n tiene un alto riesgo de desarrollar EICH?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El riesgo de desarrollar EICH es mayor:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Si recibe un trasplante de un donante con incompatibilidad HLA que est\u00e1 emparentado<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si recibe un trasplante de un donante compatible con HLA que NO est\u00e1 emparentado<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si las c\u00e9lulas madre donadas tienen un alto n\u00famero de c\u00e9lulas T<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si tanto el donante como el receptor son mayores<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si la donante est\u00e1 embarazada o ha estado embarazada en el pasado<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si los trasplantes se producen entre sexos no compatibles, por ejemplo, si el donante es hombre y el receptor es mujer, y viceversa<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">El riesgo de EICH tambi\u00e9n var\u00eda seg\u00fan la fuente de las c\u00e9lulas madre, si se obtienen del torrente sangu\u00edneo del donante o de la m\u00e9dula \u00f3sea.&nbsp;<\/span><br>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_GvHD_Diagnosed_and_Treated\"><\/span>\u00bfC\u00f3mo se diagnostica y se trata la EICH?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Diagn\u00f3stico y pruebas<\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Durante una exploraci\u00f3n f\u00edsica, su profesional de la salud puede diagnosticar la EICH bas\u00e1ndose en ciertos s\u00edntomas, los resultados de an\u00e1lisis de sangre y biopsias. Durante una biopsia, se toma una muestra de tejido o c\u00e9lulas y se env\u00eda a un laboratorio para su an\u00e1lisis.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Estrategias de tratamiento<\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Para prevenir la EICH, su profesional de la salud le recetar\u00e1 medicamentos profil\u00e1cticos (preventivos) que inhiben el sistema inmunitario. Algunos ejemplos de estos medicamentos son la ciclosporina, el metotrexato o el tacrolim\u00fas. Esto ayuda a disminuir la capacidad de las c\u00e9lulas del donante para generar una respuesta inmunitaria contra los tejidos del hu\u00e9sped.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Si se presenta EICH, para s\u00edntomas leves como erupciones cut\u00e1neas, se recetan ung\u00fcentos con esteroides. Para casos m\u00e1s graves, se recetan medicamentos como inmunosupresores (p. ej., corticosteroides) y antiinflamatorios (p. ej., <\/span><a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-inflectra-infliximab-dyyb\/\"><span style=\"font-weight: 400;\">infliximab<\/span><\/a><span style=\"font-weight: 400;\">), y <\/span><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\"><span style=\"font-weight: 400;\">IgIV<\/span><\/a><span style=\"font-weight: 400;\"> Se utilizan para reducir la inflamaci\u00f3n y aliviar los s\u00edntomas. Estos tratamientos se adaptar\u00e1n a sus necesidades seg\u00fan la gravedad y el tipo de EICH.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Are_There_Any_Potential_Benefits_of_Graft-Versus-Host_Disease\"><\/span>\u00bfExisten beneficios potenciales de la enfermedad de injerto contra hu\u00e9sped?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La EICH tiene ciertas ventajas, aunque puede tener un efecto perjudicial en la calidad de vida. Las c\u00e9lulas cancerosas que sobreviven son detectadas y eliminadas por el mismo sistema inmunitario que atac\u00f3 a las c\u00e9lulas sanas. A esto le llamamos... <\/span><b>efecto injerto contra tumor<\/b><span style=\"font-weight: 400;\">.&nbsp;<\/span><br>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Can_GvHD_Be_Prevented_in_Patients_Undergoing_Allogeneic_Transplantation\"><\/span>\u00bfC\u00f3mo se puede prevenir la EICH en pacientes sometidos a trasplante alog\u00e9nico?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La EICH se puede prevenir en pacientes mediante una cuidadosa selecci\u00f3n del donante compatible. La tipificaci\u00f3n y la compatibilidad de HLA son los dos m\u00e9todos utilizados para seleccionar al donante m\u00e1s compatible posible para el trasplante.<\/span><br>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>La enfermedad de injerto contra hu\u00e9sped (EICH) es una de las complicaciones comunes del trasplante alog\u00e9nico, un procedimiento en el que se trasplantan c\u00e9lulas madre sanas de un donante al cuerpo del paciente. La EICH se produce cuando algunas de las c\u00e9lulas del donante reci\u00e9n trasplantado (injerto) no reconocen el cuerpo del paciente (hu\u00e9sped) y atacan a sus c\u00e9lulas sanas.\u00a0<\/p>","protected":false},"author":27,"featured_media":23941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[33],"class_list":["post-23939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments<\/title>\n<meta name=\"description\" content=\"This article discusses graft-versus-host disease and provides details about the types of GvHD, symptoms, and potential treatment options.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments\" \/>\n<meta property=\"og:description\" content=\"This article discusses graft-versus-host disease and provides details about the types of GvHD, symptoms, and potential treatment options.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-08T21:02:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-09T23:56:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments\",\"datePublished\":\"2024-03-08T21:02:29+00:00\",\"dateModified\":\"2024-07-09T23:56:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/\"},\"wordCount\":947,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctor-patient.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/\",\"name\":\"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctor-patient.jpg\",\"datePublished\":\"2024-03-08T21:02:29+00:00\",\"dateModified\":\"2024-07-09T23:56:11+00:00\",\"description\":\"This article discusses graft-versus-host disease and provides details about the types of GvHD, symptoms, and potential treatment options.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctor-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/doctor-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor consulting with patient about graft-versus-host disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Descifrando la enfermedad de injerto contra hu\u00e9sped: tipos, s\u00edntomas y tratamientos","description":"Este art\u00edculo analiza la enfermedad de injerto contra hu\u00e9sped y proporciona detalles sobre los tipos de EICH, los s\u00edntomas y las posibles opciones de tratamiento.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/","og_locale":"es_MX","og_type":"article","og_title":"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments","og_description":"This article discusses graft-versus-host disease and provides details about the types of GvHD, symptoms, and potential treatment options.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-03-08T21:02:29+00:00","article_modified_time":"2024-07-09T23:56:11+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments","datePublished":"2024-03-08T21:02:29+00:00","dateModified":"2024-07-09T23:56:11+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/"},"wordCount":947,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/","url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/","name":"Descifrando la enfermedad de injerto contra hu\u00e9sped: tipos, s\u00edntomas y tratamientos","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg","datePublished":"2024-03-08T21:02:29+00:00","dateModified":"2024-07-09T23:56:11+00:00","description":"Este art\u00edculo analiza la enfermedad de injerto contra hu\u00e9sped y proporciona detalles sobre los tipos de EICH, los s\u00edntomas y las posibles opciones de tratamiento.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg","width":1280,"height":853,"caption":"Doctor consulting with patient about graft-versus-host disease"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/decoding-graft-versus-host-disease-types-symptoms-and-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Decoding Graft-Versus-Host Disease: Types, Symptoms, and Treatments"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"Graft-versus-host disease (GvHD) is one of the common complications of allogeneic transplantation \u2014 a procedure in which healthy stem cells taken from a donor are transplanted into the patient's body. GvHD occurs when some of the newly transplanted donor's cells (graft) do not recognize the patient\u2019s (host) body and attack their healthy cells.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/03\/doctor-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Graft-versus-host disease (GvHD) is one of the common complications of allogeneic transplantation \u2014 a procedure in which healthy stem cells taken from a donor are transplanted into the patient's body. GvHD occurs when some of the newly transplanted donor's cells (graft) do not recognize the patient\u2019s (host) body and attack their healthy cells.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23939"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23939\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23941"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23939"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}